QuidelOrtho (QDEL) Long-Term Investments (2022 - 2023)
QuidelOrtho (QDEL) posted Long-Term Investments of $7.4 million for Q4 2023, down 37.82% sequentially from $11.9 million in Q4 2023, and down 64.76% YoY from $21.0 million in Q4 2022.
QuidelOrtho (QDEL) Long-Term Investments (2022 - 2023) Analysis & Trends
QuidelOrtho has reported Long-Term Investments for 2 years, with the latest figure at $7.4 million in Q4 2023.
- Quarterly Long-Term Investments fell 64.76% year-over-year to $7.4 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $7.4 million (down 64.76% YoY) and the FY2023 annual result came in at $7.4 million, down 64.76% from the prior year.
- Long-Term Investments retreated to $7.4 million in Q4 2023 per QDEL's latest filing, from $11.9 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $37.9 million in Q1 2022 and troughed at $7.4 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 2.25 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 244.10 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 175.52 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | - |
| 10 | QuidelOrtho | 992.74 Mn | 869.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 7.40 Mn |
| Oct 1, 2023 | 11.90 Mn |
| Jul 2, 2023 | 24.70 Mn |
| Apr 2, 2023 | 33.80 Mn |
| Jan 1, 2023 | 21.00 Mn |
| Oct 2, 2022 | 20.30 Mn |
| Jul 3, 2022 | 15.20 Mn |
| Jan 2, 2022 | 37.90 Mn |